Janux Therapeutics Inc (JANX)
50.47
+3.97
(+8.54%)
USD |
NASDAQ |
Nov 22, 16:00
50.47
0.00 (0.00%)
After-Hours: 17:16
Janux Therapeutics Total Liabilities (Quarterly): 38.92M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 38.92M |
| June 30, 2024 | 33.74M |
| March 31, 2024 | 33.22M |
| December 31, 2023 | 36.06M |
| September 30, 2023 | 37.90M |
| June 30, 2023 | 42.03M |
| March 31, 2023 | 41.69M |
| December 31, 2022 | 43.27M |
| Date | Value |
|---|---|
| September 30, 2022 | 44.24M |
| June 30, 2022 | 41.55M |
| March 31, 2022 | 12.52M |
| December 31, 2021 | 13.50M |
| September 30, 2021 | 14.33M |
| June 30, 2021 | 12.03M |
| March 31, 2021 | 88.59M |
| December 31, 2020 | 30.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.03M
Minimum
Jun 2021
88.59M
Maximum
Mar 2021
35.28M
Average
36.98M
Median
Total Liabilities (Quarterly) Benchmarks
| Dynavax Technologies Corp | 380.56M |
| Krystal Biotech Inc | 96.47M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 695.02M |
| Shareholders Equity (Quarterly) | 656.10M |
| Current Ratio | 38.80 |